PolyNovo Chairman, David Williams, said, “While the burn trial was ultimately not needed for ARTG or CE approval, the excellent results, while expected, will strengthen our marketing to surgeons worldwide.”
Ann: CE Mark Burn Trial Results, page-2
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.030(1.29%) |
Mkt cap ! $1.587B | |||
| Open | High | Low | Value | Volume |
| $2.38 | $2.38 | $2.29 | $2.291M | 989.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2733 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.31 | 19664 | 7 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |